Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
ArkBio Presented at the 8th Annual IPF Summit and Announced Completion of Patient Enrollment for Phase 2 Clinical Trial of AK3280, a Next-Generation Drug for IPF Treatment 2024-08-27 09:00
Fujitsu tackles 'drug loss' in Japan through ecosystem to accelerate digitalization of clinical trials 2024-08-27 08:07
Telix Announces Reorganisation to Deliver on Strategic Priorities 2024-08-27 07:15
Seegene Develops mpox PCR Test Assays following the WHO Global Health Emergency Declaration 2024-08-26 21:00
CStone Reports 2024 Interim Results and Recent Corporate Updates 2024-08-23 22:20
Antengene Announces 2024 Interim Financial Results, Highlights Progress in R&D and Commercialization 2024-08-23 12:32
Ascentage Pharma Announces 2024 Interim Results 2024-08-22 23:36
Telix 2024 Half-Year Results: Strong Commercial Revenue and Profit Growth to Support Strategic Priorities 2024-08-22 17:04
Inaugural Process Innovation Asia Pacific to Drive Industry Transformation for South-East Asia's Chemicals and Pharmaceuticals 2024-08-22 15:30
China's First Approved KRAS G12C Inhibitor: Innovent Announces the Approval of Dupert® (Fulzerasib) by the National Medical Products Administration of China 2024-08-22 08:00
Targeted Pre-Launch Scientific Outreach Drives 40% Faster Treatment Adoption 2024-08-21 09:00
Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) Second NDA Accepted by NPMA, locally advanced or metastatic EGFR-mutant NSCLC 2024-08-20 16:32
Infinitus Highlights Modernizing Traditional Prescriptions at ICMCM 2024-08-20 15:09
Alphamab Oncology Reports 2024 Interim Results and Business Highlights 2024-08-16 11:18
NANOFORM COLLABORATES WITH TAKEDA ON THEIR PLASMA-DERIVED THERAPY DEVELOPMENT 2024-08-15 13:43
Docquity Drives Demand for SIT Pharma's Duo Probiotics in Thailand, Achieving 31% Sales Growth in 6 months 2024-08-13 10:00
Registrational Phase III Study of Lisaftoclax in Newly-Diagnosed Patients with Higher-Risk Myelodysplastic Syndrome Cleared by China CDE 2024-08-13 09:52
Biosyngen's BRG01 Receives FDA Approval for Phase II Clinical Trial 2024-08-13 09:00
AI in the IVF Process is the Standard of Care at Virtus Fertility Centre Singapore 2024-08-13 08:44
Lynk Pharmaceuticals Announces Positive Results from Phase 1b Clinical Study of LNK01004 for the Treatment of Atopic Dermatitis 2024-08-13 08:00
1 12 13 14 15 16 252